The panelist discusses Rebyota, a treatment approved by the FDA for preventing recurrent Clostridioides difficile infections in adults who have completed antibiotic treatment for recurrent C difficile ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...
There are several anticonvulsant drugs that are commonly prescribed. Understanding how your medications work, and their possible side effects, is an important component of your treatment. Dilantin ...
Here we describe historical, current and future therapies to treat orthopoxvirus diseases ... CMX001 and ST-246 are the only anti-poxvirus drugs currently in clinical trial.
Dr Reddy’s Laboratories on November 28 launched India's first immuno-oncology drug, Toripalimab, to treat a rare form of cancer. The drug is approved for the treatment of nasopharyngeal ...
The proposed rule could give millions of Americans access to the new drugs ... treatment,” said Chiquita Brooks-LaSure, the administrator of the Centers for Medicare and Medicaid Services, or C ...